Informace o publikaci

Editorial: Precision/Personalized Pediatric Oncology and Immune Therapies: Rather Customize Than Randomize

Autoři

KÝR Michal KLEMENT Giannoula ZDRAŽILOVÁ DUBSKÁ Lenka DEMLOVÁ Regina VALÍK Dalibor SLABÝ Ondřej SLAVC Irene ŠTĚRBA Jaroslav

Rok publikování 2020
Druh Článek v odborném periodiku (nerecenzovaný)
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
Popis Personalization of treatment based on biological markers is being utilized in clinical medicine with increasing frequency. This trend, despite an effort to identify possible common patterns, reflects the reality that no two patients are alike, and no single clinical course is identical; not even within a group of seemingly similar patients. There are numerous clinical variations related to host or environment-dependent factors. Numerous examples of these interpersonal differences have been recognized with drugs such as pain-control medications, heart medications, or antimicrobials. The differences have been attributed to increased pharmacometabolic capacity, to different individual microbiomes and to genetic differences between individuals (2). The latter has led to development of an entirely new specialty—pharmacogenomics. While this clinical heterogeneity is well-appreciated in most major medical specialties, clinical oncology seems to represent, surprisingly enough, one of the exceptions.
Související projekty:

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info